Its not the drug Herceptin being tested, it is the delivery method DEP. The Herceptin by itself had poor results as did the Kadcyla and Saline. The model shows that when the Herceptin and DEP were added together where the DEP is the delivery vehicle, there was a significant improvement. Herceptin can kill the cancer efficiently if it is administered by the DEP technology.
Its not the drug Herceptin being tested, it is the delivery...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.81M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 394540 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 57000 | 3 |
View Market Depth
| Last trade - 10.37am 13/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable